Tianjin, China

Daoke Dou

This inventor holds 1 USPTO granted patent. Top assignee: Apotex Inc.. Active years: 2020.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Daoke Dou - Innovator in Pharmaceutical Processes

Introduction

Daoke Dou is a prominent inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of Ribociclib, a drug used in cancer treatment. His innovative approaches have led to advancements in the synthesis of important pharmaceutical compounds.

Latest Patents

Daoke Dou holds a patent for "Processes for the preparation of Ribociclib and intermediates thereof." This invention provides detailed processes for the preparation of Ribociclib, as well as intermediates that are useful in its synthesis. Specifically, the patent outlines methods for preparing a compound of Formula (4) and its conversion to Ribociclib (1). This patent showcases his expertise in chemical processes and drug development.

Career Highlights

Daoke Dou is associated with Apotex Inc., a leading global pharmaceutical company. His work at Apotex has allowed him to focus on innovative drug development and contribute to the advancement of medical science. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Throughout his career, Daoke Dou has collaborated with notable colleagues, including Kangying Li and Fuchang Zhang. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Daoke Dou's contributions to the pharmaceutical industry, particularly through his patent on Ribociclib preparation, highlight his role as an influential inventor. His work continues to impact the development of essential medications, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…